Ratings Hepsiburada

Equities

HEPS

US23292B1044

Delayed Nasdaq 03:58:56 2024-05-17 pm EDT 5-day change 1st Jan Change
1.68 USD +3.70% Intraday chart for Hepsiburada +5.66% -6.67%

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • The company shows low valuation levels, with an enterprise value at -0.11 times its sales.
  • Given the positive cash flows generated by its business, the company's valuation level is an asset.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
  • Consensus analysts have strongly revised their opinion of the company over the past 12 months.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • Low profitability weakens the company.
  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 3.82 times its estimated earnings per share for the ongoing year.
  • The company appears highly valued given the size of its balance sheet.
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Sector: Department Stores

1st Jan change Capi. Investor Rating ESG Refinitiv
-6.67% 521M -
+22.36% 52.44B
B
+41.72% 40.89B -
+16.58% 10.33B
B
+8.78% 8.37B
C
-21.10% 7.49B
C
+13.51% 6.85B
B-
+2.16% 5.9B
D+
+6.56% 5.29B
C
-52.12% 3.74B
B+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW